Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2022

Open Access 01-12-2022 | Metabolic Acidosis | Case report

Treatment of critical aluminum phosphide (rice tablet) poisoning with high-dose insulin: a case report

Author: Moslem Sedaghattalab

Published in: Journal of Medical Case Reports | Issue 1/2022

Login to get access

Abstract

Background

Aluminum phosphide (rice tablet) is a highly efficient agent for preserving grains against rodents and insects. It accounts for a large number of poisoning cases. Aluminum phosphide poisoning has a high mortality rate of about 90%, and to date, no antidote is available. It releases phosphine gas after exposure to moisture, and this reaction is catalyzed by the acidity of the stomach. Phosphine is then absorbed throughout the respiratory or gastrointestinal tracts and causes toxicity through inhibition of cytochrome c oxidase and formation of highly reactive free radicals. Treatment of patients with aluminum phosphide poisoning is supportive, including mechanical ventilation and vasopressors. The usage of infusion of glucose-insulin-potassium in rice tablet poisoning has been suggested, after its positive beneficial cardiac inotropic effects in patients with beta-blocker and calcium channel blocker poisoning.

Case presentation

We report the case of a 30-year-old Iranian woman with critical aluminum phosphide poisoning, presented with hypotension and other signs of shock and severe metabolic acidosis, successfully treated with high-dose regular insulin and hypertonic dextrose and discharged from hospital in good condition. In contrast to our previous experiences, in which nearly all patients with critical aluminum phosphide poisoning died, this patient was saved with glucose-insulin-potassium.

Conclusion

Aluminum phosphide poisoning has a high mortality rate, and to date, no antidote is available. Administration of high-dose intravenous regular insulin and dextrose is suggested as a potential life-saving treatment for patients with critical aluminum phosphide poisoning.
Literature
1.
go back to reference Pannu AK, Bhalla A, Gantala J, Sharma N, Kumar S, Dhibar DP. Glucose-insulin-potassium infusion for the treatment of acute aluminum phosphide poisoning: an open-label pilot study. Clin Toxicol. 2020;58:1004–9.CrossRef Pannu AK, Bhalla A, Gantala J, Sharma N, Kumar S, Dhibar DP. Glucose-insulin-potassium infusion for the treatment of acute aluminum phosphide poisoning: an open-label pilot study. Clin Toxicol. 2020;58:1004–9.CrossRef
2.
go back to reference Etemadi-Aleagha A, Akhgari M, Iravani FS. Aluminum phosphide poisoning-related deaths in Tehran, Iran, 2006 to 2013. Medicine. 2015;94(38):e1637.CrossRef Etemadi-Aleagha A, Akhgari M, Iravani FS. Aluminum phosphide poisoning-related deaths in Tehran, Iran, 2006 to 2013. Medicine. 2015;94(38):e1637.CrossRef
3.
go back to reference Shadnia S, Mehrpour O, Soltaninejad K. A simplified acute physiology score in the prediction of acute aluminum phosphide poisoning outcome. Indian J Med Sci. 2010;64:532.CrossRef Shadnia S, Mehrpour O, Soltaninejad K. A simplified acute physiology score in the prediction of acute aluminum phosphide poisoning outcome. Indian J Med Sci. 2010;64:532.CrossRef
4.
go back to reference Gurjar M, Baronia AK, Azim A, Sharma K. Managing aluminum phosphide poisonings. J Emerg Trauma Shock. 2011;4:378.CrossRef Gurjar M, Baronia AK, Azim A, Sharma K. Managing aluminum phosphide poisonings. J Emerg Trauma Shock. 2011;4:378.CrossRef
5.
go back to reference Kerns W II, Schroeder D, Williams C, Tomaszewski C, Raymond R. Insulin improves survival in a canine model of acute β-blocker toxicity. Ann Emerg Med. 1997;29:748–57.CrossRef Kerns W II, Schroeder D, Williams C, Tomaszewski C, Raymond R. Insulin improves survival in a canine model of acute β-blocker toxicity. Ann Emerg Med. 1997;29:748–57.CrossRef
6.
go back to reference Yuan TH, Kerns WP, Tomaszewski CA, Ford MD, Kline JA, Kline J. Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning. J Toxicol Clin Toxicol. 1999;37:463–74.CrossRef Yuan TH, Kerns WP, Tomaszewski CA, Ford MD, Kline JA, Kline J. Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning. J Toxicol Clin Toxicol. 1999;37:463–74.CrossRef
7.
go back to reference Hassanian-Moghaddam H, Zamani N. Therapeutic role of hyperinsulinemia/euglycemia in aluminum phosphide poisoning. Medicine. 2016;95(31):e4349.CrossRef Hassanian-Moghaddam H, Zamani N. Therapeutic role of hyperinsulinemia/euglycemia in aluminum phosphide poisoning. Medicine. 2016;95(31):e4349.CrossRef
8.
go back to reference Woodward C, Pourmand A, Mazer-Amirshahi M. High dose insulin therapy, an evidence based approach to beta blocker/calcium channel blocker toxicity. DARU J Pharmaceut Sci. 2014;22:1–5.CrossRef Woodward C, Pourmand A, Mazer-Amirshahi M. High dose insulin therapy, an evidence based approach to beta blocker/calcium channel blocker toxicity. DARU J Pharmaceut Sci. 2014;22:1–5.CrossRef
9.
go back to reference Hassanian-Moghaddam H. NACCT AbstractsAbstracts of the 2008 North American Congress of Clinical Toxicology Annual Meeting, September 11–16, 2008, Toronto, Canada. ClinTox (Phila). 2008;46:591–645. Hassanian-Moghaddam H. NACCT AbstractsAbstracts of the 2008 North American Congress of Clinical Toxicology Annual Meeting, September 11–16, 2008, Toronto, Canada. ClinTox (Phila). 2008;46:591–645.
10.
go back to reference Engebretsen KM, Kaczmarek KM, Morgan J, Holger JS. High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning. Clin Toxicol. 2011;49:277–83.CrossRef Engebretsen KM, Kaczmarek KM, Morgan J, Holger JS. High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning. Clin Toxicol. 2011;49:277–83.CrossRef
Metadata
Title
Treatment of critical aluminum phosphide (rice tablet) poisoning with high-dose insulin: a case report
Author
Moslem Sedaghattalab
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2022
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-022-03425-4

Other articles of this Issue 1/2022

Journal of Medical Case Reports 1/2022 Go to the issue